ADC Therapeutics Newsroom

RBC Capital Maintains ADC Therapeutics(ADCT.US) With Buy Rating, Maintains Target Price $8

Futu NewsNov 8 20:31

ADC Therapeutics Initiated at Overweight by Stephens & Co.

Dow JonesNov 8 20:18

ADC Therapeutics Analyst Ratings

BenzingaNov 8 20:08

ADC Therapeutics (ADCT) Receives a Buy From RBC Capital

TipRanksNov 8 20:07

Stephens Initiates ADC Therapeutics(ADCT.US) With Buy Rating, Announces Target Price $6

Futu NewsNov 8 06:31

ADC Therapeutics Price Target Maintained With a $8.00/Share by RBC Capital

Dow JonesAug 7 23:43

ADC Therapeutics Analyst Ratings

BenzingaAug 7 23:32

RBC Capital Reaffirms Their Buy Rating on ADC Therapeutics (ADCT)

TipRanksAug 7 19:27

Capital One Financial Maintains ADC Therapeutics(ADCT.US) With Buy Rating, Cuts Target Price to $9

Futu NewsAug 7 09:31

Buy Rating Upheld for ADC Therapeutics SA Amidst Strong Financials and Promising Oncology Pipeline

TipRanksAug 7 08:37

ADC Therapeutics Analyst Ratings

BenzingaMay 30 21:00

Buy Rating Affirmed for ADC Therapeutics on Strong Zynlonta Clinical Data and Strategic Growth Outlook

TipRanksMay 7 20:21

ADC Therapeutics Analyst Ratings

BenzingaMay 7 18:30

HC Wainwright & Co. Maintains Buy on ADC Therapeutics, Lowers Price Target to $8

BenzingaMay 7 18:30

ADC Therapeutics Analyst Ratings

BenzingaApr 15 19:55

Buy Rating Affirmed for ADC Therapeutics on Strong Preclinical Data and Promising Trial Progress

TipRanksApr 15 18:26

Analysts Conflicted on These Healthcare Names: ADC Therapeutics (ADCT), Adial Pharmaceuticals (ADIL) and Steris (STE)

TipRanksApr 11 23:35

ADC Therapeutics Analyst Ratings

BenzingaApr 5 21:55

Analysts' Top Healthcare Picks: ADC Therapeutics (ADCT), TFF Pharmaceuticals (TFFP)

TipRanksApr 5 01:25

ADC Therapeutics Analyst Ratings

BenzingaMar 28 18:50